Abstract:Stroke is a leading cause of long-term disability. All neuroprotectants targeting excitotoxicity have failed to become stroke medications. In order to explore and identify new therapeutic targets for stroke, we here reviewed present studies of ionic transporters and channels that are involved in ischemic brain damage.We surveyed recent literature from animal experiments and clinical reports in the databases of PubMed and Elsevier ScienceDirect to analyze ionic mechanisms underlying ischemic cell damage and suggest promising ideas for stroke therapy.Dysfunction of ionic transporters and disrupted ionic homeostasis are most early changes that underlie ischemic brain injury, thus receiving sustained attention in translational stroke research. The Na(+)/K(+)-ATPase, Na(+)/Ca(2+) Exchanger, ionotropic glutamate receptor, acid-sensing ion channels (ASICs), sulfonylurea receptor isoform 1 (SUR1)-regulated NCCa-ATP channels, and transient receptor potential (TRP) channels are critically involved in ischemia-induced cellular degenerating processes such as cytotoxic edema, excitotoxicity, necrosis, apoptosis, and autophagic cell death. Some ionic transporters/channels also act as signalosomes to regulate cell death signaling. For acute stroke treatment, glutamate-mediated excitotoxicity must be interfered within 2 hours after stroke. The SUR1-regulated NCCa-ATP channels, Na(+)/K(+)-ATPase, ASICs, and TRP channels have a much longer therapeutic window, providing new therapeutic targets for developing feasible pharmacological treatments toward acute ischemic stroke.The next generation of stroke therapy can apply a polypharmacology strategy for which drugs are designed to target multiple ion transporters/channels or their interaction with neurotoxic signaling pathways. But a successful translation of neuroprotectants relies on in-depth analyses of cell death mechanisms and suitable animal models resembling human stroke.

Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation

Network-Based Approach to Identify Potential Targets and Drugs That Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke

Targeting Neutrophils in Ischemic Stroke: Translational Insights from Experimental Studies

Research Progress of Natural Products for the Treatment of Ischemic Stroke.

Pathophysiology and Therapeutic Potential of NADPH Oxidases in Ischemic Stroke-Induced Oxidative Stress.

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Cerebral Ischemia/Reperfusion Injury and Pharmacologic Preconditioning as a Means to Reduce Stroke-induced Inflammation and Damage

Targeting Nitrosative Stress as a Therapeutic Strategy for Neurovascular Protection in Brain Ischemia

Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury

NADPH Oxidase: A Potential Target for Treatment of Stroke

Advance in neuroprotective therapy for ischemic stroke

Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke

Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: A review

Excitatory Synaptic Transmission in Ischemic Stroke: A New Outlet for Classical Neuroprotective Strategies

Neuroprotective Treatments for Ischemic Stroke: Opportunities for Nanotechnology

Targeting oxidative stress for the treatment of ischemic stroke: Upstream and downstream therapeutic strategies

Disrupted Ionic Homeostasis in Ischemic Stroke and New Therapeutic Targets.

Excitotoxic Storms of Ischemic Stroke: A Non-neuronal Perspective

Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives

Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia

Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications